Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 21Head & Neck 12Thoracic 7Gynecologic 4Other neoplasm 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Precancerous Conditions 2Papillomavirus Infections 2Head and Neck Neoplasms 2Tongue Neoplasms 1

Interventions

Polymerase Chain Reaction 4Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Light Coagulation 2Cytogenetic Analysis 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Busulfan 2alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Soybean Proteins 1Rosuvastatin Calcium 1Paclitaxel 1Moxifloxacin 1Morphine 1Microarray Analysis 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Cetuximab × Other neoplasm × Clear all
NCT01302834 2026-01-12

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
987 enrolled 59 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Papillomavirus Infections

NCT01084083 2023-06-28

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
90 enrolled 7 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡